Shernan Holtan

Associate Professor of Medicine
Division of Hematology, Oncology, and Transplantation


Dr. Holtan is an Associate Professor of Medicine in the Division of Hematology, Oncology, and Transplantation, where she serves as a hematologist focusing on allogeneic hematopoietic cell transplantation for malignant and non-malignant diseases, and long-term survivorship. Dr. Holtan brings a clinical/translational investigator focus on personalized immune monitoring, inflammation resolution, and the role of wound healing-associated growth factors in graft-versus-host disease. Her most recent research focuses on strength training and late effects related to transplantation. Dr. Holtan brings a strong track record of multidisciplinary research to the University of Minnesota.

Research Summary

Personalized immune monitoring Inflammation resolution in GVHD Immunology of pregnancy Immunology of Cancer Strength Training

Clinical Summary

BMT; cell therapy; GVHD; late effects

Selected Publications

Selected Publications

Chen, D., Hoyer, J. D., Ketterling, R. P., Tefferi, A., Steensma, D. P., Holtan, S. G., Santana-Davila, R., Porrata, L. F., Dewald, G. W., Hanson, C. A., 2009. Dysgranulopoiesis is an independent adverse prognostic factor in chronic myeloid disorders with an isolated interstitial deletion of chromosome 5q.. Leukemia, 23 (4): 796-800.
doi: PubMed ID: 18946493.